Loading cancer entity…
Loading cancer entity…
Clinical trials
17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01901562 | Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge | terminated | N/A | 9 | Montefiore Medical CenterOTHER | 1 | Nov 9, 2023 | clinicaltrials |
| NCT01234480 | Intended Use Study of the BD SurePath Plus™ Pap | terminated | — | 5,859 | Becton, Dickinson and CompanyINDUSTRY | 1 | May 16, 2023 | clinicaltrials |
| NCT00591305 | New Therapy of Laryngeal Papilloma In Children | terminated | N/A | 1 | Boston UniversityOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT00592319 | Celebrex (Celecoxib) Treatment of Laryngeal Papilloma |
Data updated 22 days agoSource updated Nov 9, 2023source: clinicaltrials
| terminated |
| Phase 2 |
| 10 |
| Boston UniversityOTHER |
| 1 |
| Aug 31, 2012 |
| clinicaltrials |